Rosei, Enrico Agabiti <br/><br/>
Effects of candesartan cilexetil and enalapril on inflammatory markers of atherosclerosis in hypertensive patients with non-insulin-dependent diabetes mellitus.  [electronic resource] 

 -  Journal of hypertension  Feb 2005 
 - 435-44 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0263-6352 
<br/><br/><label>Standard No.: </label>10.1097/00004872-200502000-00027  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Albuminuria--drug therapy<br/>Angiotensin II Type 1 Receptor Blockers--pharmacology<br/>Angiotensin-Converting Enzyme Inhibitors--pharmacology<br/>Arteriosclerosis--drug therapy<br/>Benzimidazoles--adverse effects<br/>Biomarkers--blood<br/>Biphenyl Compounds--adverse effects<br/>Blood Pressure--drug effects<br/>Diabetes Mellitus, Type 2--complications<br/>Double-Blind Method<br/>Enalapril--adverse effects<br/>Female<br/>Fibrinogen--analysis<br/>Humans<br/>Hypertension--drug therapy<br/>Intercellular Adhesion Molecule-1--blood<br/>Male<br/>Middle Aged<br/>Plasminogen Activator Inhibitor 1--blood<br/>Tetrazoles--adverse effects<br/>Vascular Cell Adhesion Molecule-1--blood<br/>von Willebrand Factor--analysis